Meeting
2022 ASCO Annual Meeting
An update on the overall epidemiology, clinical characteristics, and outcomes from the COVID-19 and Cancer Consortium (CCC19).
Authors
Dimpy P Shah
University of Texas Health Science Center San Antonio, San Antonio, TX
Dimpy P Shah , Pankil Shah , Jeremy Lyle Warner , Gerald Batist , Christopher Ryan Friese , Elizabeth A. Griffiths , Clara Hwang , Kendra Vieira , Rana R. McKay , Ruben A. Mesa , Matthew Puc , Elizabeth M Robilotti , Erika Ruiz-Garcia , Andrew Jay Portuguese , Andrew Lachlan Schmidt , Lisa B. Weissmann , Trisha Michel Wise-Draper , Jill Barnholtz-Sloan , Solange Peters , Petros Grivas
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Etiology/Epidemiology
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 10565)
DOI
10.1200/JCO.2022.40.16_suppl.10565
Abstract #
10565
Poster Bd #
441
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Initial report on hospitalized cancer patients with COVID-19 from the National Cancer Institute (NCI) COVID-19 in Cancer Patients Study (NCCAPS).
First Author: Nicholas M. Mark
Poster
2024 ASCO Breakthrough
Mortality and economic cost in common primary cancer admitted with COVID-19: Analysis of NIS 2020.
First Author: Thanathip Suenghataiphorn
Poster
2023 ASCO Annual Meeting
Impact of SARS-COV2 infection on the clinical outcomes in patients with lung cancer compared to all other cancers.
First Author: Vaishali Deenadayalan
Poster
2023 ASCO Genitourinary Cancers Symposium
Clinical characteristics and outcomes of SARS-CoV-2 infection in patients with genitourinary cancer.
First Author: Dorothy Kenny